440 related articles for article (PubMed ID: 28315432)
1. Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer.
Kędzierska H; Piekiełko-Witkowska A
Cancer Lett; 2017 Jun; 396():53-65. PubMed ID: 28315432
[TBL] [Abstract][Full Text] [Related]
2. Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms.
Erkelenz S; Mueller WF; Evans MS; Busch A; Schöneweis K; Hertel KJ; Schaal H
RNA; 2013 Jan; 19(1):96-102. PubMed ID: 23175589
[TBL] [Abstract][Full Text] [Related]
3. SRSF10 Connects DNA Damage to the Alternative Splicing of Transcripts Encoding Apoptosis, Cell-Cycle Control, and DNA Repair Factors.
Shkreta L; Toutant J; Durand M; Manley JL; Chabot B
Cell Rep; 2016 Nov; 17(8):1990-2003. PubMed ID: 27851963
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin-c isoform levels are associated with SR and hnRNP differential expression in ovarian cancer cell lines.
Marques DS; Grativol J; Alves da Silva Peres R; da Rocha Matos A; Gimba ERP
Tumour Biol; 2017 Sep; 39(9):1010428317725442. PubMed ID: 28936921
[TBL] [Abstract][Full Text] [Related]
5. Increased stability of heterogeneous ribonucleoproteins by a deacetylase inhibitor.
Koumbadinga GA; Mahmood N; Lei L; Kan Y; Cao W; Lobo VG; Yao X; Zhang S; Xie J
Biochim Biophys Acta; 2015 Aug; 1849(8):1095-103. PubMed ID: 25959059
[TBL] [Abstract][Full Text] [Related]
6. Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.
Piekielko-Witkowska A; Wiszomirska H; Wojcicka A; Poplawski P; Boguslawska J; Tanski Z; Nauman A
PLoS One; 2010 Oct; 5(10):e13690. PubMed ID: 21082031
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Mcl-1 alternative splicing by hnRNP F, H1 and K in breast cancer cells.
Tyson-Capper A; Gautrey H
RNA Biol; 2018; 15(12):1448-1457. PubMed ID: 30468106
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia alters splicing of the cancer associated Fas gene.
Peciuliene I; Vilys L; Jakubauskiene E; Zaliauskiene L; Kanopka A
Exp Cell Res; 2019 Jul; 380(1):29-35. PubMed ID: 31002816
[TBL] [Abstract][Full Text] [Related]
9. microRNA-mediated regulation of splicing factors SRSF1, SRSF2 and hnRNP A1 in context of their alternatively spliced 3'UTRs.
Sokół E; Kędzierska H; Czubaty A; Rybicka B; Rodzik K; Tański Z; Bogusławska J; Piekiełko-Witkowska A
Exp Cell Res; 2018 Feb; 363(2):208-217. PubMed ID: 29331391
[TBL] [Abstract][Full Text] [Related]
10. Fyn/heterogeneous nuclear ribonucleoprotein E1 signaling regulates pancreatic cancer metastasis by affecting the alternative splicing of integrin β1.
Jiang P; Li Z; Tian F; Li X; Yang J
Int J Oncol; 2017 Jul; 51(1):169-183. PubMed ID: 28560430
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
12. Global Transcriptomics Uncovers Distinct Contributions From Splicing Regulatory Proteins to the Macrophage Innate Immune Response.
Wagner AR; Scott HM; West KO; Vail KJ; Fitzsimons TC; Coleman AK; Carter KE; Watson RO; Patrick KL
Front Immunol; 2021; 12():656885. PubMed ID: 34305890
[TBL] [Abstract][Full Text] [Related]
13. Srrm234, but not canonical SR and hnRNP proteins, drive inclusion of
Ustaoglu P; Haussmann IU; Liao H; Torres-Mendez A; Arnold R; Irimia M; Soller M
RNA; 2019 Oct; 25(10):1353-1365. PubMed ID: 31292260
[TBL] [Abstract][Full Text] [Related]
14. How is Herstatin, a tumor suppressor splice variant of the oncogene HER2, regulated?
Silipo M; Gautrey H; Satam S; Lennard T; Tyson-Capper A
RNA Biol; 2017 May; 14(5):536-543. PubMed ID: 27935425
[TBL] [Abstract][Full Text] [Related]
15. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
Tange TO; Damgaard CK; Guth S; Valcárcel J; Kjems J
EMBO J; 2001 Oct; 20(20):5748-58. PubMed ID: 11598017
[TBL] [Abstract][Full Text] [Related]
16. Multiple and specific mRNA processing targets for the major human hnRNP proteins.
Venables JP; Koh CS; Froehlich U; Lapointe E; Couture S; Inkel L; Bramard A; Paquet ER; Watier V; Durand M; Lucier JF; Gervais-Bird J; Tremblay K; Prinos P; Klinck R; Elela SA; Chabot B
Mol Cell Biol; 2008 Oct; 28(19):6033-43. PubMed ID: 18644864
[TBL] [Abstract][Full Text] [Related]
17. The Involvement of Splicing Factor hnRNP A1 in UVB-induced Alternative Splicing of hdm2.
Feng J; Li L; Tong L; Tang L; Wu S
Photochem Photobiol; 2016 Mar; 92(2):318-324. PubMed ID: 26757361
[TBL] [Abstract][Full Text] [Related]
18. Role of Heterogeneous Nuclear Ribonucleoproteins in the Cancer-Immune Landscape.
Sudhakaran M; Doseff AI
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982162
[TBL] [Abstract][Full Text] [Related]
19. Identification of heterogenous nuclear ribonucleoproteins (hnRNPs) and serine- and arginine-rich (SR) proteins that induce human papillomavirus type 16 late gene expression and alter L1 mRNA splicing.
Hao C; Gong L; Cui X; Jönsson J; Zheng Y; Wu C; Kajitani N; Schwartz S
Arch Virol; 2022 Feb; 167(2):563-570. PubMed ID: 34860285
[TBL] [Abstract][Full Text] [Related]
20. Amiloride modulates alternative splicing in leukemic cells and resensitizes Bcr-AblT315I mutant cells to imatinib.
Chang WH; Liu TC; Yang WK; Lee CC; Lin YH; Chen TY; Chang JG
Cancer Res; 2011 Jan; 71(2):383-92. PubMed ID: 21224352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
